WASTING SYNDROME IN AIDS - PATHOPHYSIOLOGIC MECHANISMS AND THERAPEUTIC APPROACHES

被引:0
|
作者
WEINROTH, SE [1 ]
PARENTI, DM [1 ]
SIMON, GL [1 ]
机构
[1] GEORGE WASHINGTON UNIV, MED CTR, DEPT MED, DIV INFECT DIS, WASHINGTON, DC 20037 USA
来源
INFECTIOUS AGENTS AND DISEASE-REVIEWS ISSUES AND COMMENTARY | 1995年 / 4卷 / 02期
关键词
WASTING SYNDROME; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ETIOLOGIC FACTORS; HYPERMETABOLISM; THERAPY;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Wasting syndrome is a common complication of HIV infection and is marked by progressive weight loss and weakness, often associated with fever and diarrhea. The pathophysiologic mechanisms responsible for this syndrome are not well defined, but it is clear that this is a multifactorial process in which the relative contribution of individual etiologic factors vary among patients. Considerations include inadequate diet, malabsorptive phenomena, metabolic derangements, and cytokine activity. The onset of opportunistic infections is often accompanied by a hypermetabolic state characterized by progressive weight loss. Potential cytokines that may promote weight loss in AIDS patients include tumor necrosis factor, interleukin-1, interleukin-6, and alpha-interferon. At present there is no effective treatment. Multiple therapeutic methods, including enteral and parenteral alimentation, appetite stimulants, recombinant growth hormone, and cytokine modulators, are currently being explored.
引用
收藏
页码:76 / 94
页数:19
相关论文
共 50 条
  • [21] PULMONARY-EDEMA - PATHOPHYSIOLOGIC MECHANISMS AND NEW APPROACHES TO THERAPY
    BERNARD, GR
    BRIGHAM, KL
    CHEST, 1986, 89 (04) : 594 - 600
  • [22] Thiamine Deficiency: An Update of Pathophysiologic Mechanisms and Future Therapeutic Considerations
    Abdou, Eman
    Hazell, Alan S.
    NEUROCHEMICAL RESEARCH, 2015, 40 (02) : 353 - 361
  • [23] Selectins in the HIT syndrome: Pathophysiologic role and therapeutic modulation
    Fareed, J
    Walenga, JM
    Hoppensteadt, DA
    Jeske, WP
    Lietz, H
    Ahmad, S
    Callas, D
    Messmore, HL
    Haas, S
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 : 37 - 42
  • [24] THE IDIOPATHIC HYPEREOSINOPHILIC SYNDROME - CLINICAL, PATHOPHYSIOLOGIC, AND THERAPEUTIC CONSIDERATIONS
    FAUCI, AS
    HARLEY, JB
    ROBERTS, WC
    FERRANS, VJ
    GRALNICK, HR
    BJORNSON, BH
    ANNALS OF INTERNAL MEDICINE, 1982, 97 (01) : 78 - 92
  • [25] Thiamine Deficiency: An Update of Pathophysiologic Mechanisms and Future Therapeutic Considerations
    Eman Abdou
    Alan S. Hazell
    Neurochemical Research, 2015, 40 : 353 - 361
  • [26] Which pathophysiologic mechanisms are relevant therapeutic targets in ischemic stroke?
    Heiss, WD
    Kracht, LW
    Thiel, A
    Grond, M
    Pawlik, G
    Graf, R
    PHARMACOLOGY OF CEREBRAL ISCHEMIA 2000, 2000, : 519 - 524
  • [28] Metabolic syndrome in patients with schizophrenia: Underlying mechanisms and therapeutic approaches (Review)
    Manta, Aspasia
    Georganta, Anastasia
    Roumpou, Afroditi
    Zoumpourlis, Vassilis
    Spandidos, Demetrios A.
    Rizos, Emmanouil
    Peppa, Melpomeni
    MOLECULAR MEDICINE REPORTS, 2025, 31 (05)
  • [29] Molecular mechanisms of fragile X syndrome reveal potential therapeutic approaches
    Warren, ST
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S71 - S71
  • [30] Thalamocortical circuits in generalized epilepsy: Pathophysiologic mechanisms and therapeutic targets
    Lindquist, Britta E.
    Timbie, Clare
    Voskobiynyk, Yuliya
    Paz, Jeanne T.
    NEUROBIOLOGY OF DISEASE, 2023, 181